Found: 173
Select item for more details and to access through your institution.
Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 300, doi. 10.1111/apt.18104
- By:
- Publication type:
- Article
Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision? Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 5, p. 1301, doi. 10.1111/bcp.16017
- By:
- Publication type:
- Article
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 285, doi. 10.1007/s40261-024-01353-3
- By:
- Publication type:
- Article
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 4, p. 578, doi. 10.1093/ecco-jcc/jjad184
- By:
- Publication type:
- Article
De-escalation of Biologic Treatment in Inflammatory Bowel Disease: A Comprehensive Review.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 4, p. 642, doi. 10.1093/ecco-jcc/jjad181
- By:
- Publication type:
- Article
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1383704
- By:
- Publication type:
- Article
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1342477
- By:
- Publication type:
- Article
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1342477
- By:
- Publication type:
- Article
Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 2, p. 136, doi. 10.3390/antibiotics13020136
- By:
- Publication type:
- Article
Helicobacter pylori Eradication Treatment in Older Patients.
- Published in:
- Drugs & Aging, 2024, v. 41, n. 2, p. 141, doi. 10.1007/s40266-023-01090-w
- By:
- Publication type:
- Article
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 2, p. 212, doi. 10.1093/ecco-jcc/jjad140
- By:
- Publication type:
- Article
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1342477
- By:
- Publication type:
- Article
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 1, p. 134, doi. 10.1093/ecco-jcc/jjad118
- By:
- Publication type:
- Article
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease.
- Published in:
- BioDrugs, 2023, v. 37, n. 6, p. 873, doi. 10.1007/s40259-023-00616-3
- By:
- Publication type:
- Article
Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 21, p. 15691, doi. 10.3390/ijms242115691
- By:
- Publication type:
- Article
Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease.
- Published in:
- Biomedicines, 2023, v. 11, n. 10, p. 2831, doi. 10.3390/biomedicines11102831
- By:
- Publication type:
- Article
Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn's Disease.
- Published in:
- Drugs, 2023, v. 83, n. 13, p. 1179, doi. 10.1007/s40265-023-01916-2
- By:
- Publication type:
- Article
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 7, p. 1031, doi. 10.1093/ecco-jcc/jjad001
- By:
- Publication type:
- Article
Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 12, p. 10159, doi. 10.3390/ijms241210159
- By:
- Publication type:
- Article
Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 6, p. 972, doi. 10.1093/ecco-jcc/jjad004
- By:
- Publication type:
- Article
Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 6, p. 995, doi. 10.1093/ecco-jcc/jjad005
- By:
- Publication type:
- Article
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF Drugs.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 8695, doi. 10.3390/ijms24108695
- By:
- Publication type:
- Article
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 1, p. 83, doi. 10.1093/ecco-jcc/jjac108
- By:
- Publication type:
- Article
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's Disease.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15881, doi. 10.3390/ijms232415881
- By:
- Publication type:
- Article
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII).
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7540, doi. 10.3390/jcm11247540
- By:
- Publication type:
- Article
Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.966184
- By:
- Publication type:
- Article
Editorial: slow progress to optimising H. pylori eradication treatment with antisecretory drugs.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 6, p. 1074, doi. 10.1111/apt.17142
- By:
- Publication type:
- Article
Evaluation of a New Monoclonal Chemiluminescent Immunoassay Stool Antigen Test for the Diagnosis of Helicobacter pylori Infection: A Spanish Multicentre Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5077, doi. 10.3390/jcm11175077
- By:
- Publication type:
- Article
Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081885
- By:
- Publication type:
- Article
Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Systematic Review and Meta-Analysis of Observational Studies.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 14, p. 4202, doi. 10.3390/jcm11144202
- By:
- Publication type:
- Article
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 7, p. 1070, doi. 10.1093/ecco-jcc/jjac010
- By:
- Publication type:
- Article
Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacter pylori Infection (Hp-EuReg).
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 12, p. 3544, doi. 10.3390/jcm11123544
- By:
- Publication type:
- Article
Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.913436
- By:
- Publication type:
- Article
Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 940, doi. 10.1093/ecco-jcc/jjab217
- By:
- Publication type:
- Article
Evaluation of Natural Language Processing for the Identification of Crohn Disease–Related Variables in Spanish Electronic Health Records: A Validation Study for the PREMONITION-CD Project.
- Published in:
- JMIR Medical Informatics, 2022, v. 10, n. 2, p. 49, doi. 10.2196/30345
- By:
- Publication type:
- Article
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 2, p. 179, doi. 10.1093/ecco-jcc/jjab177
- By:
- Publication type:
- Article
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 2, p. 421, doi. 10.3390/jcm11020421
- By:
- Publication type:
- Article
Assessment of first-line eradication treatment in Greece: data from the European Registry on Helicobacter pylori management (Hp-EuReg).
- Published in:
- Annals of Gastroenterology, 2022, v. 35, n. 1, p. 42, doi. 10.20524/aog.2021.0670
- By:
- Publication type:
- Article
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 1, p. 2, doi. 10.1093/ecco-jcc/jjab178
- By:
- Publication type:
- Article
Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 22, p. 5318, doi. 10.3390/jcm10225318
- By:
- Publication type:
- Article
Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 11, p. 1190, doi. 10.3390/ph14111190
- By:
- Publication type:
- Article
Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10224, doi. 10.3390/ijms221910224
- By:
- Publication type:
- Article
Rescue Therapy with Furazolidone in Patients with at Least Five Eradication Treatment Failures and Multi-Resistant H. pylori infection.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 9, p. 1028, doi. 10.3390/antibiotics10091028
- By:
- Publication type:
- Article
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Editorial: withdrawal of anti‐TNFalpha—are we ready for biological therapy cycling? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 1, p. 86, doi. 10.1111/apt.16406
- By:
- Publication type:
- Article
Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract.
- Published in:
- Molecular Nutrition & Food Research, 2021, v. 65, n. 12, p. 1, doi. 10.1002/mnfr.202001034
- By:
- Publication type:
- Article
The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211018097
- By:
- Publication type:
- Article
Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2760, doi. 10.3390/cancers13112760
- By:
- Publication type:
- Article
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.
- Published in:
- 2021
- By:
- Publication type:
- journal article